These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33090696)

  • 1. Sex differences in antiviral immunity in SARS-CoV-2 infection: Mitochondria and mitomiR come into view.
    Iessi E; Cittadini C; Anticoli S; Fecchi K; Matarrese P; Ruggieri A
    Acta Physiol (Oxf); 2021 Feb; 231(2):e13571. PubMed ID: 33090696
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary for Patients: What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
    Ann Intern Med; 2021 Jun; 174(6):I26. PubMed ID: 33721515
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19: A Mitochondrial Perspective.
    Prasun P
    DNA Cell Biol; 2021 Jun; 40(6):713-719. PubMed ID: 33872068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.
    Li C; Tian X; Jia X; Wan J; Lu L; Jiang S; Lan F; Lu Y; Wu Y; Ying T
    Signal Transduct Target Ther; 2021 Mar; 6(1):132. PubMed ID: 33758169
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
    Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
    J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection.
    Russell MW; Moldoveanu Z; Ogra PL; Mestecky J
    Front Immunol; 2020; 11():611337. PubMed ID: 33329607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
    Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection.
    Sauerwald N; Zhang Z; Ramos I; Nair VD; Soares-Schanoski A; Ge Y; Mao W; Alshammary H; Gonzalez-Reiche AS; van de Guchte A; Goforth CW; Lizewski RA; Lizewski SE; Amper MAS; Vasoya M; Seenarine N; Guevara K; Marjanovic N; Miller CM; Nudelman G; Schilling MA; Sealfon RSG; Termini MS; Vangeti S; Weir DL; Zaslavsky E; Chikina M; Wu YN; Van Bakel H; Letizia AG; Sealfon SC; Troyanskaya OG
    Cell Syst; 2022 Nov; 13(11):924-931.e4. PubMed ID: 36323307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
    Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
    Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development.
    Li T; Kan Q; Ge J; Wan Z; Yuan M; Huang Y; Xie Q; Yang Y; Shao H; Li X; Ye L; Qin A; Bu Z; Liu P; Ye J
    Cell Mol Immunol; 2021 Nov; 18(11):2563-2565. PubMed ID: 34645942
    [No Abstract]   [Full Text] [Related]  

  • 14. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.
    Goodhue Meyer EK; Xu M; Lasky B; Young PP
    Transfusion; 2021 Jan; 61(1):330-331. PubMed ID: 33037643
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response.
    Guo G; Gao M; Gao X; Zhu B; Huang J; Luo K; Zhang Y; Sun J; Deng M; Lou Z
    Signal Transduct Target Ther; 2021 Mar; 6(1):119. PubMed ID: 33707416
    [No Abstract]   [Full Text] [Related]  

  • 17. SnapShot: SARS-CoV-2 antibodies.
    Montefiori DC; Acharya P
    Cell Host Microbe; 2021 Jul; 29(7):1162-1162.e1. PubMed ID: 34265246
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.
    Zhou Z; Zhang X; Lei X; Xiao X; Jiao T; Ma R; Dong X; Jiang Q; Wang W; Shi Y; Zheng T; Rao J; Xiang Z; Ren L; Deng T; Jiang Z; Dou Z; Wei W; Wang J
    Signal Transduct Target Ther; 2021 Nov; 6(1):382. PubMed ID: 34732709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.